dorsaVi provided an update in relation to a near term enhancement of dorsaVi's Run Module that combines wearable sensor data with AI algorithms and video techniques. In April 2023, dorsaVi released the new Run Module into its best-selling product ViMove+, which offers users a simple and effective method of assessing patient's running performance. This module forms a key part of dorsaVi's broader product and solutions portfolio, addressing a significant unmet need from athletes, coaches, and physical therapists to analyse live running motion data and receive insights in real-time.

Traditionally, clinicians and leading coaches have been required to use video tracking and sensor technology separately, with no comprehensive solution available in the market currently. By applying available technology in the market, dorsaVi will combine top-tier video tracking software with its leading sensor technology to offer a single solution at minimal development cost to the Company. The product enhancements leverage proprietary AI algorithms and intellectual property developed by dorsaVi and other open-source AI development platforms. By implementing these next-generation algorithms, dorsaVi's solution can automatically track the angular mechanics of runners, displaying animated lines over video streams as illustrated in Figure 1. This feature provides coaches and clinicians access to valuable information on the angles of the ankle, hip, or knee at foot strike which surpass what can be recognised by the naked eye.

Image is not representative of final product and is subject to change. Video information will be available alongside data from dorsaVi's wearable sensors which leverage output from an accelerometer, gyroscope and magnetometer to capture high-precision, stride-by-stride running metrics, such as Ground Reaction Force (GRF), Initial Peak Acceleration (IPA), Ground Contact Time (GCT), and symmetry between right and left foot metrics. The inclusion of video tracking capability increases the product's functionality, allowing ViMove+ to benefit a broader patient group and expands the market opportunity.

dorsaVi is confident that the product enhancement creates a superior value proposition which will drive sales growth and generate recurring revenues. Final testing is currently underway and dorsaVi expects the enhanced Run Module to be available to customers in September this year.